BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17954785)

  • 1. Beating a dead horse: dopamine and Parkinson disease.
    Ahlskog JE
    Neurology; 2007 Oct; 69(17):1701-11. PubMed ID: 17954785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levodopa/dopamine replacement strategies in Parkinson's disease--future directions.
    Olanow CW
    Mov Disord; 2008; 23 Suppl 3():S613-22. PubMed ID: 18781663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatments for Parkinson disease--past achievements and current clinical needs.
    Poewe W
    Neurology; 2009 Feb; 72(7 Suppl):S65-73. PubMed ID: 19221317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rapid-eye-movement sleep disorders in Parkinson's disease].
    Gagnon JF; Montplaisir J; Bédard MA
    Rev Neurol (Paris); 2002 Feb; 158(2):135-52. PubMed ID: 11965170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms compensating for dopamine loss in early Parkinson disease.
    Brotchie J; Fitzer-Attas C
    Neurology; 2009 Feb; 72(7 Suppl):S32-8. PubMed ID: 19221312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of motor complications in Parkinson disease: current and emerging therapies.
    Espay AJ
    Neurol Clin; 2010 Nov; 28(4):913-25. PubMed ID: 20816270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we achieve neuroprotection with currently available anti-parkinsonian interventions?
    Olanow CW
    Neurology; 2009 Feb; 72(7 Suppl):S59-64. PubMed ID: 19221316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid resolution of dopamine dysregulation syndrome (DDS) after subthalamic DBS for Parkinson disease (PD): a case report.
    Knobel D; Aybek S; Pollo C; Vingerhoets FJ; Berney A
    Cogn Behav Neurol; 2008 Sep; 21(3):187-9. PubMed ID: 18797262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of levodopa-induced motor complications.
    Stocchi F; Tagliati M; Olanow CW
    Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The scientific and clinical basis for the treatment of Parkinson disease (2009).
    Olanow CW; Stern MB; Sethi K
    Neurology; 2009 May; 72(21 Suppl 4):S1-136. PubMed ID: 19470958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease with and without REM sleep behaviour disorder: are there any clinical differences?
    Yoritaka A; Ohizumi H; Tanaka S; Hattori N
    Eur Neurol; 2009; 61(3):164-70. PubMed ID: 19129703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimaging of nonmotor features of Parkinson's disease.
    Deblieck C; Wu AD
    Rev Neurol Dis; 2008; 5(3):125-33. PubMed ID: 18838952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Parkinson's disease in Thailand: review of the literature and practical recommendations.
    Bhidayasiri R; Ling H
    J Med Assoc Thai; 2009 Jan; 92(1):142-54. PubMed ID: 19260256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities.
    Jenner P
    Mov Disord; 2008; 23 Suppl 3():S585-98. PubMed ID: 18781676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we image premotor Parkinson disease?
    Marek K; Jennings D
    Neurology; 2009 Feb; 72(7 Suppl):S21-6. PubMed ID: 19221310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapeutic approaches to Parkinson's disease including neural transplants.
    Kuan WL; Barker RA
    Neurorehabil Neural Repair; 2005 Sep; 19(3):155-81. PubMed ID: 16093408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reevaluation of levodopa therapy for the treatment of advanced Parkinson's disease.
    Yokochi M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S25-30. PubMed ID: 19131038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease.
    Ahlskog JE
    Mov Disord; 2005 Mar; 20(3):271-82. PubMed ID: 15580550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Initial management and adaptation of Parkinson's disease treatment].
    Gérard JM
    Rev Med Brux; 2008 Sep; 29(4):229-31. PubMed ID: 18949969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.